This website is intended for healthcare professionals
This website is intended for healthcare professionals
With the help of Prescribing and Therapeutics Training Ltd and the Journal of Prescribing Practice, you can earn your 1-hour CPD certificate .
Following a deal with the manufacturer of Dexcom One, patients with type 1 diabetes in England are now eligible for continuous glucose monitors (CGMs). Until recently, the only CGMs widely available...
The National Institute of Health and Care Excellence (NICE) has published final draft guidance recommending icosapent ethyl to reduce the risk of cardiovascular events such as heart attacks and...
Dr Sharon Rees @reesprescribe.
The UK government has published a new drug safety update on the use of metformin and its effects on a patient's vitamin B12 levels..
Following the National Institute of Health and Care Excellence's (NICE) recommendation of relugolix with estradiol and norethisterone acetate in final draft guidance, around 4500 women with uterine...
The National Institute of Health and Care Excellence (NICE) has recommended an innovative and potentially life-extending drug for treating people with a specific gene mutation of advanced...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved tixagevimab/cilgavimab (Evusheld), a new monoclonal antibody combination, for COVID-19 pre-exposure prophylaxis, or...
Around 400 patients with advanced breast cancer will now be able to benefit from a new treatment after the National Institute of Health and Care Excellence (NICE) published final draft guidance...
Around 1500 people in England with spinal muscular atrophy (SMA), a rare genetic condition, will benefit from a new medicine after The National Institute for Health and Care Excellence (NICE) released...
Draft guidance, published on the 18 November, is the first time NICE has made recommendations about the use of an HIV treatment since these came under NICE's remit in 2019. It is estimated that...
Ronapreve, a combination of two monoclonal antibodies, is the first targeted medicine developed for COVID-19 to receive marketing authorisation from the Medicines and Healthcare products Regulatory...
Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.
Evidence-based best practice
Drug updates
Pharmacology information
Calculation skills